ArticleJournal of Alzheimer's disease : JAD2024

Study Partner Type and Adverse Event Reporting in Mild-to-Moderate Alzheimer's Disease Clinical Trials.

Thuy V Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.